• Author: David P Bui
Clear all

Identifying Veterans who benefit from nirmatrelvir-ritonavir: A target trial emulation

Abstract: Background: Nirmatrelvir-ritonavir is recommended for persons at risk for severe coronavirus disease 2019 (COVID-19) but remains underutilized. Information on which …